Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism

被引:353
|
作者
Hauser, David N. [1 ,2 ]
Hastings, Teresa G. [3 ,4 ,5 ]
机构
[1] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA
[2] Brown Univ, NIH, Grad Partnership Program, Dept Neurosci, Providence, RI 02912 USA
[3] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA
[5] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA
关键词
Parkinson's disease; Mitochondria; Oxidative stress; Dopamine oxidation; RAT-BRAIN MITOCHONDRIA; COMPLEX-I DEFICIENCY; RESOLUTION CRYSTAL-STRUCTURE; CYSTEINE-SULFINIC ACID; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; DOPAMINERGIC-NEURONS; DJ-1-DEFICIENT MICE; DNA DELETIONS; FAMILIAL PARKINSONISM;
D O I
10.1016/j.nbd.2012.10.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The pathogenic mechanisms that underlie Parkinson's disease remain unknown. Here, we review evidence from both sporadic and genetic forms of Parkinson's disease that implicate both mitochondria and oxidative stress as central players in disease pathogenesis. A systemic deficiency in complex I of the mitochondrial electron transport chain is evident in many patients with the disease. Oxidative stress caused by reactive metabolites of dopamine and alterations in the levels of iron and glutathione in the substantia nigra accompany this mitochondrial dysfunction. Recent evidence from studies on the genetic forms of parkinsonism with particular stress on DJ-1, parkin, and PINK-1 also suggest the involvement of mitochondria and oxidative stress. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [41] A systematic review of molecular approaches that link mitochondrial dysfunction and neuroinflammation in Parkinson's disease
    Mani, Sugumar
    Sevanan, Murugan
    Krishnamoorthy, Alagudurai
    Sekar, Sathiya
    NEUROLOGICAL SCIENCES, 2021, 42 (11) : 4459 - 4469
  • [42] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC
    Risiglione, Pierpaolo
    Zinghirino, Federica
    Di Rosa, Maria Carmela
    Magri, Andrea
    Messina, Angela
    BIOMOLECULES, 2021, 11 (05)
  • [43] Mitochondrial DNA and Primary Mitochondrial Dysfunction in Parkinson's Disease
    Giannoccaro, Maria Pia
    La Morgia, Chiara
    Rizzo, Giovanni
    Carelli, Valerio
    MOVEMENT DISORDERS, 2017, 32 (03) : 346 - 363
  • [44] Mitochondrial Pathology in Parkinson's Disease
    Schapira, Anthony H. V.
    MOUNT SINAI JOURNAL OF MEDICINE, 2011, 78 (06): : 872 - 881
  • [45] Mitochondrial dysfunction in Parkinson's disease
    Fukae, Jiro
    Mizuno, Yoshikuni
    Hattori, Nobutaka
    MITOCHONDRION, 2007, 7 (1-2) : 58 - 62
  • [46] Mitochondrial dysfunction in Parkinson's disease
    Bose, Anindita
    Beal, M. Flint
    JOURNAL OF NEUROCHEMISTRY, 2016, 139 : 216 - 231
  • [47] α-Synuclein pathology and mitochondrial dysfunction: Toxic partners in Parkinson's disease
    Mingo, Yakum B.
    Galvis, Martha L. Escobar
    Henderson, Michael X.
    NEUROBIOLOGY OF DISEASE, 2025, 209
  • [48] Regulation of SIRT3 on mitochondrial functions and oxidative stress in Parkinson's disease
    Shen, Yanhua
    Wu, Qin
    Shi, Jingshan
    Zhou, Shaoyu
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 132
  • [49] Gene Therapeutic Approaches for the Treatment of Mitochondrial Dysfunction in Parkinson's Disease
    Prasuhn, Jannik
    Brueggemann, Norbert
    GENES, 2021, 12 (11)
  • [50] Implications of p53 in mitochondrial dysfunction and Parkinson's disease
    Wang, Yi-Fan
    Wang, Ying-Di
    Gao, Song
    Sun, Wei
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2024, 134 (08) : 906 - 917